These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 34355681)
1. Value of Contrast-enhanced Magnetic Resonance Imaging (MRI) in the Diagnosis of Breast Cancer. Gonçalves MA; Pereira BTL; Tavares CA; Santos TMR; da Cunha EFF; Ramalho TC Mini Rev Med Chem; 2022; 22(6):865-872. PubMed ID: 34355681 [TBL] [Abstract][Full Text] [Related]
3. Manganese-porphyrin-enhanced MRI for the detection of cancer cells: A quantitative in vitro investigation with multiple clinical subtypes of breast cancer. Alhamami M; Cheng W; Lyu Y; Allen C; Zhang XA; Cheng HL PLoS One; 2018; 13(5):e0196998. PubMed ID: 29795583 [TBL] [Abstract][Full Text] [Related]
4. Amphiphilic branched polymer-nitroxides conjugate as a nanoscale agent for potential magnetic resonance imaging of multiple objects in vivo. Wang X; Guo S; Li Z; Luo Q; Dai Y; Zhang H; Ye Y; Gong Q; Luo K J Nanobiotechnology; 2021 Jul; 19(1):205. PubMed ID: 34243760 [TBL] [Abstract][Full Text] [Related]
6. Mn Devreux M; Henoumont C; Dioury F; Boutry S; Vacher O; Elst LV; Port M; Muller RN; Sandre O; Laurent S Inorg Chem; 2021 Mar; 60(6):3604-3619. PubMed ID: 33625836 [TBL] [Abstract][Full Text] [Related]
7. Tumor Contrast Enhancement and Whole-Body Elimination of the Manganese-Based Magnetic Resonance Imaging Contrast Agent Mn-PyC3A. Erstad DJ; Ramsay IA; Jordan VC; Sojoodi M; Fuchs BC; Tanabe KK; Caravan P; Gale EM Invest Radiol; 2019 Nov; 54(11):697-703. PubMed ID: 31356382 [TBL] [Abstract][Full Text] [Related]
8. [Contrast agent-free breast MRI : Advantages and potential disadvantages]. Baltzer PAT; Kapetas P; Sodano C; Dietzel M; Pinker K; Helbich TH; Clauser P Radiologe; 2019 Jun; 59(6):510-516. PubMed ID: 31001650 [TBL] [Abstract][Full Text] [Related]
9. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents. Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343 [TBL] [Abstract][Full Text] [Related]
10. Accuracy of Contrast-Enhanced Ultrasound Compared With Magnetic Resonance Imaging in Assessing the Tumor Response After Neoadjuvant Chemotherapy for Breast Cancer. Lee SC; Grant E; Sheth P; Garcia AA; Desai B; Ji L; Groshen S; Hwang D; Yamashita M; Hovanessian-Larsen L J Ultrasound Med; 2017 May; 36(5):901-911. PubMed ID: 28150325 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of contrast Sonazoid-enhanced ultrasonography for the detection of hepatic metastases in breast cancer. Mishima M; Toh U; Iwakuma N; Takenaka M; Furukawa M; Akagi Y Breast Cancer; 2016 Mar; 23(2):231-41. PubMed ID: 25143060 [TBL] [Abstract][Full Text] [Related]
12. Role of diffusion weighted imaging and magnetic resonance spectroscopy in breast cancer patients with indeterminate dynamic contrast enhanced magnetic resonance imaging findings. Sharma U; Agarwal K; Hari S; Mathur SR; Seenu V; Parshad R; Jagannathan NR Magn Reson Imaging; 2019 Sep; 61():66-72. PubMed ID: 31128225 [TBL] [Abstract][Full Text] [Related]
13. New magnetic resonance imaging techniques for the detection of breast cancer. Orang-Khadivi K; Pierce BL; Ollom CM; Floyd LJ; Siegle RL; Williams RF Breast Cancer Res Treat; 1994; 32(1):119-35. PubMed ID: 7819581 [TBL] [Abstract][Full Text] [Related]
14. Addition of T2-guided optical tomography improves noncontrast breast magnetic resonance imaging diagnosis. Feng J; Xu J; Jiang S; Yin H; Zhao Y; Gui J; Wang K; Lv X; Ren F; Pogue BW; Paulsen KD Breast Cancer Res; 2017 Oct; 19(1):117. PubMed ID: 29065920 [TBL] [Abstract][Full Text] [Related]
15. Integrating Fluorinated Polymer and Manganese-Layered Double Hydroxide Nanoparticles as pH-activated Zhang C; Li L; Han FY; Yu X; Tan X; Fu C; Xu ZP; Whittaker AK Small; 2019 Sep; 15(36):e1902309. PubMed ID: 31328398 [No Abstract] [Full Text] [Related]
16. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging. Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604 [TBL] [Abstract][Full Text] [Related]
17. Triple-negative breast cancer on contrast-enhanced MRI and synthetic MRI: A comparison with non-triple-negative breast carcinoma. Matsuda M; Tsuda T; Ebihara R; Toshimori W; Okada K; Takeda S; Okumura A; Shiraishi Y; Suekuni H; Kamei Y; Kurata M; Kitazawa R; Mochizuki T; Kido T Eur J Radiol; 2021 Sep; 142():109838. PubMed ID: 34217136 [TBL] [Abstract][Full Text] [Related]
18. Sensitivity of enhanced MRI for the detection of breast cancer: new, multicentric, residual, and recurrent. Davis PL; McCarty KS Eur Radiol; 1997; 7 Suppl 5():289-98. PubMed ID: 9370561 [TBL] [Abstract][Full Text] [Related]
19. Non-contrast enhanced MRI for evaluation of breast lesions: comparison of non-contrast enhanced high spectral and spatial resolution (HiSS) images versus contrast enhanced fat-suppressed images. Medved M; Fan X; Abe H; Newstead GM; Wood AM; Shimauchi A; Kulkarni K; Ivancevic MK; Pesce LL; Olopade OI; Karczmar GS Acad Radiol; 2011 Dec; 18(12):1467-74. PubMed ID: 21962476 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and Relaxometric Characterization of New Poly[N,N-bis(3-aminopropyl)glycine] (PAPGly) Dendrons Gd-Based Contrast Agents and Their in Vivo Study by Using the Dynamic Contrast-Enhanced MRI Technique at Low Field (1 T). Granato L; Longo D; Boutry S; Vander Elst L; Henoumont C; Aime S; Muller RN; Laurent S Chem Biodivers; 2019 Nov; 16(11):e1900322. PubMed ID: 31544357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]